EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   2.3.2.31 | Adenomatous Polyposis Coli |
33404293 |
BNIP3L-mediated mitophagy is required for mitochondrial remodeling during the differentiation of optic nerve oligodendrocytes. |
ongoing research
unassigned |
1
0 |
| 2.3.2.31 | Adrenocortical Carcinoma |
22427816 |
Knockdown of SF-1 and RNF31 affects components of steroidogenesis, TGF?, and Wnt/?-catenin signaling in adrenocortical carcinoma cells. |
unassigned |
0 |
| 2.3.2.31 | Alzheimer Disease |
30290714 |
PRKN-regulated mitophagy and cellular senescence during COPD pathogenesis. |
causal interaction
ongoing research
unassigned |
1
1
0 |
| 2.3.2.31 | Alzheimer Disease |
32048886 |
Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles. |
unassigned |
0 |
| 2.3.2.31 | Alzheimer Disease |
32967533 |
Mitophagy in degenerative joint diseases. |
unassigned |
0 |
| 2.3.2.31 | Amyotrophic Lateral Sclerosis |
26553645 |
Mice lacking the PSD-95-interacting E3 ligase, Dorfin/Rnf19a, display reduced adult neurogenesis, enhanced long-term potentiation, and impaired contextual fear conditioning. |
unassigned |
0 |
| 2.3.2.31 | Amyotrophic Lateral Sclerosis |
32048886 |
Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles. |
unassigned |
0 |
| 2.3.2.31 | Arthritis, Rheumatoid |
30290714 |
PRKN-regulated mitophagy and cellular senescence during COPD pathogenesis. |
causal interaction
ongoing research
unassigned |
1
1
0 |
| 2.3.2.31 | Bacterial Infections |
32543267 |
LUBAC and OTULIN regulate autophagy initiation and maturation by mediating the linear ubiquitination and the stabilization of ATG13. |
therapeutic application
unassigned |
1
0 |
| 2.3.2.31 | Brain Injuries, Traumatic |
30409224 |
The expression of TRIAD1 and DISC1 after traumatic brain injury and its influence on NSCs. |
causal interaction
ongoing research
therapeutic application
unassigned |
3
3
1
0 |
